These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 866798)

  • 21. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Nagel R; Köllin CP
    Br J Urol; 1977 Feb; 49(1):73-9. PubMed ID: 837052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 23. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
    Smith PH; Robinson M; Richards B; Suciu S; De Pauw M; Sylvester R; Denis L
    Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W; Wegner G
    Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estramustine phosphate sodium.
    Hauser AR; Merryman R
    Drug Intell Clin Pharm; 1984 May; 18(5):368-74. PubMed ID: 6373212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
    Nilsson T; Jonsson G
    J Urol; 1976 Feb; 115(2):168-9. PubMed ID: 1249870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A; Shukla SK; Welvaart K; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):219-23. PubMed ID: 1093669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA; Rosenthal H; Mittelman A; Murphy GP
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT; Jones AG
    Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193
    [No Abstract]   [Full Text] [Related]  

  • 32. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A; Zattoni F; Frustaci S; Galligioni E; Tirelli U; Trovó G; Tumolo S; Merlo A; Artuso G; Cosciani-Cunico S; Grigoletto E
    Prostate; 1982; 3(2):159-64. PubMed ID: 7088731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
    Könyves I
    Int Urol Nephrol; 1989; 21(4):393-7. PubMed ID: 2693392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estracyt--clinical experiences.
    Nilsson T
    Scand J Urol Nephrol Suppl; 1980; 55():135-8. PubMed ID: 6938016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate.
    Kjaer TB; Nilsson T; Madsen PO
    Urology; 1975 Jun; 5(6):802-4. PubMed ID: 1136096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estramustine phosphate in secondary hormone-resistant carcinoma of the prostate.
    Maier U; Hienert G; Simak R
    Eur Urol; 1990; 17(3):216-8. PubMed ID: 2351191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of estramustine phosphate on prostatic cancer estimated by transrectal ultrasonotomography.
    Watanabe H; Ohe H; Ando K; Sawamura Y; Niijima T; Nakamura S; Orikasa S; Tanahashi Y; Imamura K; Yoshida H
    Prostate; 1981; 2(2):155-61. PubMed ID: 7301654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial institute.
    Murphy GP; Slack NH; Mittelman A
    Urology; 1984 Jun; 23(6 Suppl):54-63. PubMed ID: 6375081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.